Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelitis | 8 | 2022 | 49 | 2.950 |
Why?
|
Central Nervous System Viral Diseases | 7 | 2022 | 40 | 2.810 |
Why?
|
Multiple Sclerosis | 41 | 2024 | 3222 | 2.720 |
Why?
|
Neuromuscular Diseases | 7 | 2022 | 258 | 2.350 |
Why?
|
Enterovirus Infections | 3 | 2022 | 74 | 1.120 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 5 | 2022 | 269 | 1.010 |
Why?
|
Optic Neuritis | 7 | 2021 | 174 | 0.840 |
Why?
|
Autoimmune Diseases of the Nervous System | 2 | 2023 | 75 | 0.640 |
Why?
|
Neuromyelitis Optica | 4 | 2023 | 264 | 0.570 |
Why?
|
Demyelinating Diseases | 4 | 2023 | 352 | 0.520 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 521 | 0.470 |
Why?
|
Aquaporin 4 | 6 | 2023 | 161 | 0.430 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 4 | 2022 | 556 | 0.420 |
Why?
|
Child | 52 | 2024 | 80089 | 0.410 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2024 | 614 | 0.400 |
Why?
|
Hypothalamic Diseases | 2 | 2023 | 134 | 0.380 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1400 | 0.380 |
Why?
|
Age of Onset | 10 | 2024 | 3303 | 0.350 |
Why?
|
Autonomic Nervous System Diseases | 2 | 2023 | 269 | 0.340 |
Why?
|
Prader-Willi Syndrome | 1 | 2010 | 78 | 0.340 |
Why?
|
Macrophage Activation Syndrome | 2 | 2022 | 124 | 0.330 |
Why?
|
Visual Acuity | 4 | 2021 | 2676 | 0.270 |
Why?
|
Immunosuppressive Agents | 5 | 2024 | 4172 | 0.260 |
Why?
|
Adolescent | 37 | 2024 | 88247 | 0.230 |
Why?
|
Autoantibodies | 7 | 2023 | 2115 | 0.220 |
Why?
|
Primary Dysautonomias | 1 | 2023 | 28 | 0.210 |
Why?
|
Paraneoplastic Syndromes, Nervous System | 1 | 2022 | 24 | 0.200 |
Why?
|
Child, Preschool | 18 | 2024 | 42193 | 0.200 |
Why?
|
Pupil Disorders | 1 | 2021 | 33 | 0.180 |
Why?
|
Disease Progression | 7 | 2024 | 13495 | 0.180 |
Why?
|
Vision Tests | 1 | 2021 | 161 | 0.180 |
Why?
|
Humans | 69 | 2024 | 760740 | 0.170 |
Why?
|
Endocrine System Diseases | 1 | 2022 | 249 | 0.170 |
Why?
|
Parents | 3 | 2024 | 3563 | 0.170 |
Why?
|
Muscle Hypotonia | 1 | 2020 | 161 | 0.170 |
Why?
|
Enterovirus | 1 | 2019 | 67 | 0.160 |
Why?
|
Enterovirus A, Human | 1 | 2018 | 27 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 6 | 2023 | 17878 | 0.160 |
Why?
|
Education, Special | 1 | 2018 | 86 | 0.150 |
Why?
|
Case-Control Studies | 12 | 2024 | 22153 | 0.150 |
Why?
|
Ozone | 1 | 2022 | 483 | 0.150 |
Why?
|
Cognition Disorders | 3 | 2022 | 3979 | 0.150 |
Why?
|
Seroepidemiologic Studies | 1 | 2019 | 398 | 0.150 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 823 | 0.150 |
Why?
|
Self-Help Groups | 1 | 2019 | 192 | 0.150 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2020 | 254 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2020 | 412 | 0.150 |
Why?
|
Recovery of Function | 2 | 2020 | 2977 | 0.140 |
Why?
|
Female | 43 | 2024 | 392203 | 0.130 |
Why?
|
Male | 41 | 2024 | 360402 | 0.130 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2015 | 38 | 0.130 |
Why?
|
Vitamin D | 3 | 2019 | 3301 | 0.130 |
Why?
|
Forecasting | 2 | 2015 | 2924 | 0.120 |
Why?
|
Recurrence | 7 | 2023 | 8426 | 0.120 |
Why?
|
Epilepsy | 1 | 2010 | 3303 | 0.120 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 990 | 0.120 |
Why?
|
Fluoxetine | 1 | 2018 | 733 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36401 | 0.110 |
Why?
|
Antibodies | 2 | 2024 | 2413 | 0.110 |
Why?
|
Sodium Chloride, Dietary | 1 | 2016 | 292 | 0.110 |
Why?
|
United States | 16 | 2024 | 72292 | 0.110 |
Why?
|
Encephalitis | 1 | 2017 | 438 | 0.110 |
Why?
|
Herpesvirus 4, Human | 3 | 2024 | 1077 | 0.100 |
Why?
|
Environmental Exposure | 2 | 2018 | 4483 | 0.100 |
Why?
|
Hypoventilation | 2 | 2023 | 44 | 0.100 |
Why?
|
Sodium, Dietary | 1 | 2016 | 425 | 0.100 |
Why?
|
Receptors, GABA-A | 1 | 2017 | 622 | 0.100 |
Why?
|
Brain | 7 | 2024 | 27100 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2019 | 2422 | 0.100 |
Why?
|
Pediatrics | 3 | 2016 | 3589 | 0.100 |
Why?
|
Infant | 8 | 2020 | 36157 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2024 | 80583 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1852 | 0.090 |
Why?
|
Disabled Persons | 1 | 2020 | 1226 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2024 | 7805 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1509 | 0.090 |
Why?
|
Risk Factors | 13 | 2024 | 74128 | 0.080 |
Why?
|
Dietary Fats | 1 | 2017 | 1995 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2018 | 871 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2238 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6174 | 0.080 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 7995 | 0.080 |
Why?
|
Ultraviolet Rays | 2 | 2023 | 1079 | 0.070 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2014 | 1017 | 0.070 |
Why?
|
Spinal Cord | 1 | 2015 | 1807 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2019 | 15908 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15829 | 0.070 |
Why?
|
Syndrome | 2 | 2023 | 3268 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2018 | 3037 | 0.070 |
Why?
|
Canada | 2 | 2023 | 2120 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2019 | 12966 | 0.060 |
Why?
|
Hospitals, Pediatric | 1 | 2014 | 1859 | 0.060 |
Why?
|
Biomedical Research | 2 | 2024 | 3426 | 0.060 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4533 | 0.060 |
Why?
|
Sweden | 2 | 2017 | 1379 | 0.060 |
Why?
|
Diet | 2 | 2024 | 8049 | 0.060 |
Why?
|
Adult | 14 | 2024 | 220995 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2016 | 3183 | 0.060 |
Why?
|
Young Adult | 8 | 2024 | 59191 | 0.060 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 103 | 0.050 |
Why?
|
MicroRNAs | 1 | 2019 | 3802 | 0.050 |
Why?
|
Azathioprine | 1 | 2022 | 354 | 0.050 |
Why?
|
Dairy Products | 1 | 2024 | 490 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5671 | 0.040 |
Why?
|
Pain | 1 | 2015 | 5062 | 0.040 |
Why?
|
Sunlight | 1 | 2021 | 337 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14599 | 0.040 |
Why?
|
HLA-B7 Antigen | 1 | 2019 | 48 | 0.040 |
Why?
|
HLA-A3 Antigen | 1 | 2019 | 34 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12942 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12116 | 0.040 |
Why?
|
Fruit | 1 | 2024 | 1158 | 0.040 |
Why?
|
Mathematical Concepts | 1 | 2018 | 73 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54364 | 0.040 |
Why?
|
Demography | 1 | 2023 | 1643 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2022 | 7050 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2022 | 664 | 0.040 |
Why?
|
Nerve Fibers | 1 | 2021 | 707 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 12977 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1327 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1033 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39062 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1404 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9603 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41464 | 0.030 |
Why?
|
Retinal Ganglion Cells | 1 | 2021 | 810 | 0.030 |
Why?
|
Antigens, Viral | 1 | 2019 | 988 | 0.030 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2015 | 68 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3268 | 0.030 |
Why?
|
California | 1 | 2019 | 1431 | 0.030 |
Why?
|
Reading | 1 | 2018 | 531 | 0.030 |
Why?
|
Electroencephalography | 1 | 2010 | 6240 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2024 | 1589 | 0.030 |
Why?
|
Cognition | 2 | 2022 | 6988 | 0.030 |
Why?
|
Diet Surveys | 1 | 2017 | 1161 | 0.030 |
Why?
|
Movement Disorders | 1 | 2017 | 459 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13248 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2020 | 1835 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3205 | 0.030 |
Why?
|
Haplotypes | 1 | 2019 | 2713 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1912 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3705 | 0.020 |
Why?
|
Vegetables | 1 | 2017 | 1192 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2022 | 2400 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1333 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 1007 | 0.020 |
Why?
|
Consciousness | 1 | 2017 | 600 | 0.020 |
Why?
|
Retina | 1 | 2021 | 2655 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2789 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3820 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1745 | 0.020 |
Why?
|
Family | 1 | 2021 | 3193 | 0.020 |
Why?
|
Binding Sites | 1 | 2019 | 6051 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 64572 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4802 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4745 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12661 | 0.020 |
Why?
|
Databases, Factual | 2 | 2015 | 7963 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1700 | 0.020 |
Why?
|
Rats | 2 | 2017 | 23716 | 0.020 |
Why?
|
Goals | 1 | 2014 | 708 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3117 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1788 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5765 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 894 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2917 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8209 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2019 | 3149 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7236 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6339 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6861 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4269 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3680 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9644 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12043 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2017 | 3599 | 0.010 |
Why?
|
Genetic Testing | 1 | 2017 | 3533 | 0.010 |
Why?
|
Seizures | 1 | 2017 | 2964 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7373 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.010 |
Why?
|
Air Pollution | 1 | 2017 | 2355 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9417 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168202 | 0.010 |
Why?
|
Middle Aged | 4 | 2020 | 220603 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3901 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7390 | 0.010 |
Why?
|
Immunotherapy | 1 | 2017 | 4642 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12934 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20077 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26065 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10759 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15250 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26183 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39908 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14024 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18381 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23415 | 0.010 |
Why?
|
Aged | 1 | 2019 | 169092 | 0.000 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_